Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

mTORC2 signalling regulates M2 macrophage differentiation in response to helminth infection and adaptive thermogenesis

Hallowell RW., Collins SL., Craig JM., Zhang Y., Oh M., Illei PB.

Animal Study on Systemic / IV, published in Nat Commun (2017) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Nat Commun (2017)
Reported sample size
—
Source database
Europe PMC
PMID
28128208
PMCID
PMC5290163
DOI
10.1038/ncomms14208
Citations
103

Abstract (original English)

Alternatively activated macrophages (M2) have an important function in innate immune responses to parasitic helminths, and emerging evidence also indicates these cells are regulators of systemic metabolism. Here we show a critical role for mTORC2 signalling in the generation of M2 macrophages. Abrogation of mTORC2 signalling in macrophages by selective conditional deletion of the adaptor molecule Rictor inhibits the generation of M2 macrophages while leaving the generation of classically activated macrophages (M1) intact. Selective deletion of Rictor in macrophages prevents M2 differentiation and clearance of a parasitic helminth infection in mice, and also abrogates the ability of mice to regulate brown fat and maintain core body temperature. Our findings define a role for mTORC2 in macrophages in integrating signals from the immune microenvironment to promote innate type 2 immunity, and also to integrate systemic metabolic and thermogenic responses.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Cells, CulturedMacrophagesAnimalsMice, Inbred C57BLHumansMiceNippostrongylusHelminthiasis, AnimalStrongylida InfectionsDisease Models, Animal

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research